Tali Feferman

Tali Feferman

UNVERIFIED PROFILE

Are you Tali Feferman?   Register this Author

Register author
Tali Feferman

Tali Feferman

Publications by authors named "Tali Feferman"

Are you Tali Feferman?   Register this Author

27Publications

358Reads

24Profile Views

Reduced CTL motility and activity in avascular tumor areas.

Cancer Immunol Immunother 2019 Aug 28;68(8):1287-1301. Epub 2019 Jun 28.

Department of Immunology, Weizmann Institute of Science, Wolfson Bldg., 234 Herzl St., 76100, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02361-5DOI Listing
August 2019

The bone marrow is patrolled by NK cells that are primed and expand in response to systemic viral activation.

Eur J Immunol 2018 07 2;48(7):1137-1152. Epub 2018 May 2.

Department of Immunology, the Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201747378DOI Listing
July 2018

Active dissemination of cellular antigens by DCs facilitates CD8 T-cell priming in lymph nodes.

Eur J Immunol 2017 10;47(10):1802-1818

Department of Immunology and Veterinary Services, Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201747042DOI Listing
October 2017

Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.

Cell Rep 2017 Sep;20(11):2547-2555

Department of Immunology, Weizmann Institute of Science, Rehovot, 76100, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.08.071DOI Listing
September 2017

Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.

Ann N Y Acad Sci 2012 Dec;1274:120-6

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2012.06844.xDOI Listing
December 2012

Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.

Ann N Y Acad Sci 2012 Dec;1275:107-13

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2012.06843.xDOI Listing
December 2012

The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.

J Autoimmun 2011 Feb 29;36(1):16-24. Epub 2010 Oct 29.

Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100 Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2010.09.007DOI Listing
February 2011

Involvement of phosphodiesterases in autoimmune diseases.

J Neuroimmunol 2010 Mar 25;220(1-2):43-51. Epub 2010 Jan 25.

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2009.12.012DOI Listing
March 2010

Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.

J Neuroimmunol 2009 Apr 20;209(1-2):87-95. Epub 2009 Feb 20.

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2009.01.021DOI Listing
April 2009

Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.

Ann N Y Acad Sci 2008 ;1132:244-8

Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1405.032DOI Listing
September 2008

Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.

J Neuroimmunol 2008 Sep 15;201-202:128-35. Epub 2008 Jul 15.

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2008.05.023DOI Listing
September 2008

Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.

J Immunol 2008 Feb;180(4):2132-9

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.4.2132DOI Listing
February 2008

The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.

Isr Med Assoc J 2008 Jan;10(1):58-60

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
January 2008

Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.

Ann N Y Acad Sci 2007 Sep;1110:550-8

Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1423.059DOI Listing
September 2007

DNA microarray in search of new drug targets for myasthenia gravis.

Ann N Y Acad Sci 2007 Jun;1107:111-7

Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1381.012DOI Listing
June 2007

Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.

J Neuroimmunol 2006 Jul 26;176(1-2):187-97. Epub 2006 May 26.

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2006.04.011DOI Listing
July 2006

Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor.

FASEB J 2006 Feb 19;20(2):374-6. Epub 2005 Dec 19.

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.05-4909fjeDOI Listing
February 2006

Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.

J Immunol 2005 May;174(9):5324-31

Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.174.9.5324DOI Listing
May 2005

Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.

J Neuroimmunol 2004 Jul;152(1-2):112-20

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2004.04.010DOI Listing
July 2004

Epitope spreading to hidden cytoplasmic regions of the acetylcholine receptor in experimental autoimmune myasthenia gravis.

Ann N Y Acad Sci 2003 Sep;998:388-90

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1254.047DOI Listing
September 2003

Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors.

Ann N Y Acad Sci 2003 Sep;998:533-6

Department of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1254.069DOI Listing
September 2003

Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis.

J Neuroimmunol 2003 Jul;140(1-2):153-8

Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5728(03)00209-1DOI Listing
July 2003

Protective molecular mimicry in experimental myasthenia gravis.

J Neuroimmunol 2002 May;126(1-2):99-106

Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5728(02)00069-3DOI Listing
May 2002